144 related articles for article (PubMed ID: 29525482)
1. Expanded buprenorphine prescribing privileges: Sandbagging in the midst of the flood?
Brown JD; Nolte JL
Res Social Adm Pharm; 2018 Jun; 14(6):617-618. PubMed ID: 29525482
[No Abstract] [Full Text] [Related]
2. Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers.
Tierney M; Finnell DS; Naegle MA; LaBelle C; Gordon AJ
Subst Abus; 2015; 36(4):389-92. PubMed ID: 26587696
[No Abstract] [Full Text] [Related]
3. Opioid misuse epidemic: Addressing opioid prescribing and organization initiatives for holistic, safe and compassionate care.
Naegle M; ; Mitchell AM; ; Flinter M; ; Dunphy L; ; Vanhook P; ; Delaney KR;
Nurs Outlook; 2017; 65(4):477-479. PubMed ID: 28821312
[No Abstract] [Full Text] [Related]
4. Buprenorphine prescribing practice trends and attitudes among New York providers.
Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
[TBL] [Abstract][Full Text] [Related]
5. Controlling the Swing of the Opioid Pendulum.
Comerci G; Katzman J; Duhigg D
N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151
[No Abstract] [Full Text] [Related]
6. Trends in Buprenorphine Use in US Jails and Prisons From 2016 to 2021.
Thakrar AP; Alexander GC; Saloner B
JAMA Netw Open; 2021 Dec; 4(12):e2138807. PubMed ID: 34905010
[TBL] [Abstract][Full Text] [Related]
7. Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US.
Weiner SG; Qato DM; Faust JS; Clear B
JAMA Netw Open; 2023 May; 6(5):e2316089. PubMed ID: 37234009
[TBL] [Abstract][Full Text] [Related]
8. Expanding access to nurse-managed medication for opioid use disorder.
Cos TA; Starbird LE; Lee H; Chun B; Gonnella K; Bird J; Livsey K; Bastos S; O'Brien M; Clark I; Jenkins D; Tavolaro-Ryley L
Nurs Outlook; 2021; 69(5):848-855. PubMed ID: 33992445
[TBL] [Abstract][Full Text] [Related]
9. In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.
Med Lett Drugs Ther; 2013 Oct; 55(1427):83. PubMed ID: 24129113
[No Abstract] [Full Text] [Related]
10. Treatment of pain in patients taking buprenorphine for opioid addiction #221.
Childers JW; Arnold RM
J Palliat Med; 2012 May; 15(5):613-4. PubMed ID: 22577788
[No Abstract] [Full Text] [Related]
11. Two Different Buprenorphine Treatment Settings With Similar Retention Rates: Implications for Expanding Access to Treatment for Opioid Use Disorder.
Tierney M; Melino K; Adeniji A; Shumway M; Allen IE; Waters CM
J Am Psychiatr Nurses Assoc; 2019; 25(4):305-313. PubMed ID: 30295107
[No Abstract] [Full Text] [Related]
12. DEA Disconnect Leads to Buprenorphine Bottlenecks.
Ostrach B; Carpenter D; Cote LP
J Addict Med; 2021 Jul-Aug 01; 15(4):272-275. PubMed ID: 33181577
[TBL] [Abstract][Full Text] [Related]
13. Outpatient opioid addiction treatment using buprenorphine.
Roberson CM
Ala Nurse; 2010; 37(2):13-6; quiz 17. PubMed ID: 20666206
[No Abstract] [Full Text] [Related]
14. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
Trigg BG; Dickman SL
Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
[TBL] [Abstract][Full Text] [Related]
15. Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.
Dick AW; Pacula RL; Gordon AJ; Sorbero M; Burns RM; Leslie D; Stein BD
Health Aff (Millwood); 2015 Jun; 34(6):1028-34. PubMed ID: 26056209
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine Prescribing: To Expand or Not to Expand.
Li X; Shorter D; Kosten TR
J Psychiatr Pract; 2016 May; 22(3):183-92. PubMed ID: 27123798
[TBL] [Abstract][Full Text] [Related]
17. Treating opioid dependence--new data and new opportunities.
O'Connor PG
N Engl J Med; 2000 Nov; 343(18):1332-4. PubMed ID: 11058680
[No Abstract] [Full Text] [Related]
18. Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016.
Fornili KS; Fogger SA
J Addict Nurs; 2017; 28(1):43-48. PubMed ID: 28252511
[TBL] [Abstract][Full Text] [Related]
19. Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process.
Farmer CM; Lindsay D; Williams J; Ayers A; Schuster J; Cilia A; Flaherty MT; Mandell T; Gordon AJ; Stein BD
Subst Abus; 2015; 36(2):209-16. PubMed ID: 25844527
[TBL] [Abstract][Full Text] [Related]
20. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
